Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00329940
What this trial is testing

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 200
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Very early researchUnknownNCT04130750
What this trial is testing

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

Who this might be right for
Breast CancerNeoadjuvant ChemotherapyDrug Effect
Peking University People's Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06222879
What this trial is testing

Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 350
Not applicableUnknownNCT05713435
What this trial is testing

Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors

Who this might be right for
Genitourinary Syndrome of Menopause
Universitaire Ziekenhuizen KU Leuven 162
Not applicableActive Not RecruitingNCT02050750
What this trial is testing

TAILORx Tissue Bank

Who this might be right for
Breast Cancer
Cancer Trials Ireland 600
Not applicableStudy completedNCT06636591
What this trial is testing

Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

Who this might be right for
Breast Cancer FemaleHER2-negative Breast Cancer
Fudan University 14
Testing effectiveness (Phase 2)Study completedNCT00082810
What this trial is testing

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 33
Not applicableUnknownNCT01440413
What this trial is testing

Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer

Who this might be right for
Breast Cancer
Centre Leon Berard 40
Not applicableStudy completedNCT04304924
What this trial is testing

Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer

Who this might be right for
Overweight or Obese Breast Cancer Patients
Gustave Roussy, Cancer Campus, Grand Paris 220
Large-scale testing (Phase 3)UnknownNCT00025688
What this trial is testing

Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Theradex
Large-scale testing (Phase 3)UnknownNCT00408408
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,206
Not applicableLooking for participantsNCT07527689
What this trial is testing

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer

Who this might be right for
Breast Cancer
Ruijin Hospital 1,950
Not applicableUnknownNCT04550910
What this trial is testing

RCT Comparing 2 Radiotherapy HypoFractionation Schedules In Breast Cancer Patients

Who this might be right for
Radiotherapy Side EffectLocoregional Recurrence
National Cancer Institute, Egypt 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07681297
What this trial is testing

Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease

Who this might be right for
Advanced Solid Tumor CancerTriple-Negative Breast Cancer (TNBC)CNS Disease+1 more
National University Hospital, Singapore 154
Testing effectiveness (Phase 2)Study completedNCT01275859
What this trial is testing

Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 25
Not applicableEnded earlyNCT00595296
What this trial is testing

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Who this might be right for
Breast Cancer
Janssen Diagnostics, LLC 461
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Testing effectiveness (Phase 2)Looking for participantsNCT07483307
What this trial is testing

The Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 176
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Next Page